M&A

3 Drugmakers With Boatloads of Cash to Spend
Motley Fool
Wed, 03/29/17 - 04:54 pm
Pfizer
Gilead Sciences
Amgen
JNJ
M&A
Pfizer Up on Bristol-Myers Takeover Talk
Investopedia
Mon, 03/27/17 - 11:43 pm
Pfizer
Bristol-Myers Squibb
M&A
Bristol-Myers: Maybe a Pfizer Acquisition Could Makes Sense After All?
Barron's
Mon, 03/27/17 - 11:41 pm
Bristol-Myers Squibb
Pfizer
M&A
Concert rebuffed $250M buyout offer from Vertex before CF drug deal
Bizjournals.com
Sat, 03/25/17 - 11:56 am
Concert Pharmaceuticals
Vertex Pharmaceuticals
M&A
cystic fibrosis
CTP-656
Kalydeco
That $95M Merck gamble to acquire cCAM? It didn’t pay off.
Endpoints
Fri, 03/24/17 - 10:10 am
Merck
M&A
eCAM
Roger Perlmutter
R&D
Sanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source
Fierce Pharma
Thu, 03/23/17 - 09:58 pm
Sanofi
Flexion
M&A
osteoarthritis of the knee
Zilretta
Abbott Poised to Perform Well - As Long As it Closes Alere Litigation
TheStreet.com
Wed, 03/22/17 - 10:09 am
Abbott Labs
Alere
devices
M&A
What’s on the biopharma’s auction block? EY tracks a growing appetite for pipeline divestment deals
Endpoints
Tue, 03/21/17 - 11:19 am
M&A
Cerulean Pharma to cut staff, merge with San Diego biotech
Bizjournals.com
Mon, 03/20/17 - 11:25 pm
Cerulean Pharma
M&A
layoffs
Daré Bioscience
Gilead Sciences: Is an Incyte Deal ‘Reasonable’?
Barron's
Mon, 03/13/17 - 11:26 am
Gilead Sciences
Incyte
M&A
The new CEOs in biopharma are joining the big players at the billion-dollar chip table
Endpoints
Fri, 03/10/17 - 09:16 pm
Pharma CEOs
M&A
Eli Lilly
David Ricks
CoLucid Pharmaceuticals
Celgene
Gilead Sciences
GSK
Biogen
Novo Nordisk in Talks to Buy Global Blood Therapeutics
Investopedia
Fri, 03/10/17 - 11:49 am
Novo Nordisk
M&A
Global Blood Therapeutics
Merck KGaA in talks to sell its biosimilars R&D ops as shakeout looms
Endpoints
Thu, 03/9/17 - 11:36 am
Merck KGaA
biosimilars
M&A
R&D
M&A heating up among smaller I/O drugmakers
BioPharma Dive
Thu, 03/9/17 - 09:52 am
M&A
immuno-oncology
Heat Biologics
Pelican Therapeutics
Otsuka acquires ADHD drug in $100M deal for Neurovance
BioPharma Dive
Mon, 03/6/17 - 11:48 am
Otsuka
ADHD
Neurovance
centanafadine
M&A
Short Sellers Pile On Pfizer After Buyout Rumors
Yahoo/Reuters
Wed, 03/1/17 - 10:28 am
Pfizer
M&A
Johnson & Johnson closes $4.3B Abbott Medical Optics buy
Mass Device
Mon, 02/27/17 - 09:08 am
JNJ
devices
M&A
Abbott Medical Optics
eye health
Making (good) deals is hard to do, Gilead CEO says, but he's working on it
Fierce Pharma
Fri, 02/24/17 - 09:12 am
Gilead Sciences
M&A
Pharma CEOs
John Milligan
One more time: We're not buying Valeant, Allergan CEO insists
Fierce Pharma
Thu, 02/23/17 - 09:48 pm
Valeant Pharmaceuticals
Allergan
Pharma CEOs
M&A
Brent Saunders
How could you make a Bristol-Myers takeover work without shredding a $5B R&D division?
Endpoints
Thu, 02/23/17 - 09:24 pm
Bristol-Myers Squibb
R&D
M&A

Pages